56
Participants
Start Date
March 31, 2014
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
CH-Alum50
intramuscular administration to Swiss volunteers of Alhydrogel and P27A antigen (50 microg)
CH-GLA2.5/50
intramuscular administration to Swiss volunteers of GLA-SE (2.5microg) together with the P27A antigen (50 microg)
TZ Ver
intramuscular administration of Rabies vaccine Verorub TM to in Phase IIb only to 8 Tanzanian volunteers in three injections
TZ Alum 50
intramuscular administration to Tanzanian volunteers of Alhydrogel and P27A antigen (50 microg)
TZ GLA 2.5/10
intramuscular administration to Tanzanian volunteers of GLA-SE (2.5 microg ) together with the P27A antigen (10 microg)
TZ GLA5/50
intramuscular administration to Tanzanian volunteers of GLA-SE (5 microg) together with the P27A antigen (50 microg)
TZ GLA2.5/50
intramuscular administration to Tanzanian volunteers of GLA-SE (2.5microg) together with the P27A antigen (50 microg)
CHUV CRC, Lausanne
Bagamoyo Clinical Trial Unit (BCTU), Bagamoyo
European Vaccine Initiative
OTHER
European and Developing Countries Clinical Trials Partnership (EDCTP)
OTHER_GOV
Centre Hospitalier Universitaire Vaudois
OTHER